Medical Properties Trust, Inc. (MPW) Receives Consensus Rating of “Hold” from Analysts

Medical Properties Trust, Inc. (NYSE:MPW) has been given an average rating of “Hold” by the ten analysts that are presently covering the company, MarketBeat reports. Seven equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $15.08.

MPW has been the topic of a number of recent research reports. JPMorgan Chase & Co. raised shares of Medical Properties Trust from a “neutral” rating to an “overweight” rating in a report on Wednesday, December 19th. JMP Securities set a $16.00 target price on shares of Medical Properties Trust and gave the company a “buy” rating in a report on Monday, October 1st. Mitsubishi UFJ Financial Group lifted their target price on shares of Medical Properties Trust to $15.00 and gave the company a “neutral” rating in a report on Friday, November 2nd. Wells Fargo & Co raised shares of Medical Properties Trust from an “underperform” rating to a “market perform” rating and lifted their target price for the company from $13.50 to $17.50 in a report on Tuesday, December 11th. Finally, Zacks Investment Research cut shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a report on Thursday, October 25th.

MPW stock traded down $0.10 during midday trading on Tuesday, reaching $16.99. 2,196,960 shares of the company were exchanged, compared to its average volume of 3,783,062. The company has a current ratio of 4.92, a quick ratio of 4.92 and a debt-to-equity ratio of 0.90. Medical Properties Trust has a 1-year low of $11.82 and a 1-year high of $17.52. The stock has a market cap of $6.33 billion, a P/E ratio of 12.59, a PEG ratio of 6.01 and a beta of 0.56.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings data on Thursday, November 1st. The real estate investment trust reported $0.35 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.01. The company had revenue of $197.00 million for the quarter, compared to analysts’ expectations of $192.64 million. Medical Properties Trust had a net margin of 124.88% and a return on equity of 9.06%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter last year, the company earned $0.33 earnings per share. On average, equities research analysts predict that Medical Properties Trust will post 1.37 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 10th. Investors of record on Thursday, December 13th were given a $0.25 dividend. The ex-dividend date of this dividend was Wednesday, December 12th. This represents a $1.00 dividend on an annualized basis and a yield of 5.89%. Medical Properties Trust’s dividend payout ratio (DPR) is 74.07%.

In related news, Director Michael G. Stewart sold 5,800 shares of Medical Properties Trust stock in a transaction on Tuesday, December 4th. The shares were sold at an average price of $17.39, for a total value of $100,862.00. Following the transaction, the director now directly owns 225,239 shares in the company, valued at approximately $3,916,906.21. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Emmett E. Mclean sold 50,000 shares of Medical Properties Trust stock in a transaction on Tuesday, December 4th. The shares were sold at an average price of $17.40, for a total transaction of $870,000.00. Following the completion of the transaction, the insider now owns 913,965 shares in the company, valued at $15,902,991. The disclosure for this sale can be found here. Over the last quarter, insiders sold 98,865 shares of company stock worth $1,693,493. 0.83% of the stock is currently owned by insiders.

Large investors have recently bought and sold shares of the stock. Bay Colony Advisory Group Inc d b a Bay Colony Advisors boosted its position in shares of Medical Properties Trust by 49.8% during the 3rd quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors now owns 11,127 shares of the real estate investment trust’s stock worth $166,000 after purchasing an additional 3,700 shares in the last quarter. Parametrica Management Ltd purchased a new stake in shares of Medical Properties Trust during the 3rd quarter worth $185,000. Campbell & CO Investment Adviser LLC purchased a new stake in shares of Medical Properties Trust during the 3rd quarter worth $204,000. Oliver Luxxe Assets LLC purchased a new stake in shares of Medical Properties Trust during the 3rd quarter worth $217,000. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Medical Properties Trust during the 2nd quarter worth $230,000. Hedge funds and other institutional investors own 75.48% of the company’s stock.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Featured Article: Price-Sales Ratio

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply